Bristol-Myers' Opdivo-Yervoy combo hits a regulatory snag in lung cancer
admin 22nd October 2018 Uncategorised 0Bristol-Myers Squibb presented a raft of results for its Opdivo-Yervoy immuno-oncology combo across multiple tumor types at the European Society for Medical Oncology meeting. But results it didn’t present stole the weekend spotlight.
More: Bristol-Myers' Opdivo-Yervoy combo hits a regulatory snag in lung cancer
Source: fierce